If you’ve recently been diagnosed with pulmonary fibrosis, there are probably loads of questions running through your mind. Here are some of the most important questions you should ask your doctor according to the American Lung Association. 1. “What is pulmonary fibrosis?” Pulmonary fibrosis (PF) literally means scarring of the lungs.
Patients with idiopathic pulmonary fibrosis (IPF) who demonstrate adequate lung volume still have the same rate of lung volume decline as patients with initially lower volumes, and benefit equally from treatment with Ofev (nintedanib), researchers reported. The study, “Nintedanib in patients with idiopathic pulmonary fibrosis and preserved…
Idiopathic Pulmonary fibrosis (IPF) is a difficult disease to diagnose because many of its symptoms are similar to other lung diseases. There is no one single test for the condition. Instead, a series of tests are carried out to diagnose the condition. One test is auscultation.
Allakos recently presented preclinical data demonstrating the potential of its Siglec-8 antibodies in inhibiting components involved in fibrosis in rodent models of lung and skin fibrosis. The company believes these antibodies could potentially benefit a wide spectrum of patients with conditions where fibrosis is a major contributor to the…
What is Aromatherapy? Have you heard about essential oils? They aren’t anything new. “Essential oil” is basically a different name for an old standby, aromatherapy. There’s plenty of research behind this aromatic trend that shows it can help to alleviate many health conditions. We’ve uncovered some ways essential oils can help you deal…
In this PeerView Press video, pulmonologist Dr. David J. Lederer discusses idiopathic pulmonary fibrosis (IPF), with a focus on personalized care through communications and innovative strategies. He is joined by primary care physician Dr. Steven J. Antonini and pulmonary fibrosis patient Robert Brynteson. Read about six lesser-known symptoms…
Building on previous research, scientists at Brown University report that a trio of proteins work together to promote a variety of lung diseases, including idiopathic pulmonary fibrosis (IPF). The findings, published by investigators led by Jack Elias in the journal Nature Communications, appeared in the article “IL-13Rα2 Uses TMEM219 In…
Pulmonary fibrosis is a chronic severe lung disease that occurs when lung tissue becomes scarred and thickened. Patients struggle with breathing difficulties, a persistent dry cough, fatigue, weight loss, and clubbing of the fingers. Read about six less common symptoms of idiopathic pulmonary fibrosis here. In this video from Boehringer Ingelheim Idiopathic…
Global Blood Therapeutics (GBT) recently published positive preclinical results supporting the development of GBT440 for the treatment of lung diseases associated with hypoxemia (abnormally low levels of oxygen in the blood), such as idiopathic pulmonary fibrosis (IPF). The results were detailed in the study, “Increased hemoglobin–oxygen affinity ameliorates bleomycin‐induced hypoxemia…
Idiopathic pulmonary fibrosis is a relatively rare and serious condition. Although men tend to be affected more than women, anyone can get the disease. Some risk factors for IPF are smoking, working with environmental pollutants, acid reflux, and a family history of the disease. Read our article Simple Facts…
Get regular updates to your inbox.
